// App-Quantinova.ai

13466 : Adjusted Risk Survival Benefit Following Angiographic Complete Percutaneous Revascularization in the Era of Drug-Eluting Stents

Researchers

Presenter

  • Sa`ar Minha

Principal Investigators

  • Israel M Barbash

  • William O Suddath

  • Kenneth M Kent

  • Lowell F Satler

  • Augusto D Pichard

  • Ron Waksman

  • Hironori Kitabata

  • Salem M Badr

  • Omar Alfazir

  • Joshua P Loh

  • Pendyala K Lakshmana

  • Hideaki Ota

  • Rebecca Torguson

  • Fang Chen

Medical Centers

  • Medstar Washington Hosp Ctr, Washington, DC

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • Estrogen receptor alpha

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved